About: Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $23.64 (-0.30%)
BCAXNASDAQBicara Therapeutics Inc. Common Stock
Bicara Therapeutics Inc. Common Stock share price
BCAX price activity
Last Price
$23.640
Change (24hr)
-0.07 USD (-0.30%)
Volume
547.36K
Volume (4w avg)
-
Open
$23.37
Day Range
$23.10 - $23.93
Previous Close
$23.71
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
BCAX price performance
Delayed
09 Sep, 8:00 pm GMT+0
BCAX Market Signals